Organon (MEX:OGN) Change In Inventory : MXN-2,849 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Organon Change In Inventory?

Organon's change in inventory for the quarter that ended in Mar. 2025 was MXN61 Mil. It means Organon's inventory declined by MXN61 Mil from Dec. 2024 to Mar. 2025 .

Organon's change in inventory for the fiscal year that ended in Dec. 2024 was MXN-2,732 Mil. It means Organon's inventory increased by MXN2,732 Mil from Dec. 2023 to Dec. 2024 .

Organon's Total Inventories for the quarter that ended in Mar. 2025 was MXN27,864 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Organon's Days Inventory for the quarter that ended in Mar. 2025 was 183.90.

Inventory Turnover measures how fast the company turns over its inventory within a year. Organon's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.50.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Organon's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.90.

Organon Change In Inventory Historical Data

The historical data trend for Organon's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Change In Inventory Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

676.33

-2,830.93

-4,289.12

-3,904.08

-2,732.10

Organon Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															315.33	-1,062.57	-1,201.11	-646.53	61.38

Organon Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-2,849 Mil.

Organon (MEX:OGN) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Organon's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	27707.224	/	13747.911	*	365 / 4
	=	183.90

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Organon's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	13747.911	/	27707.224
	=	0.50

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Organon's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	27707.224	/	30953.257
	=	0.90

Organon Change In Inventory Related Terms

Thank you for viewing the detailed overview of Organon's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (MEX:OGN) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

OGN:USA 1OGN:Italy 0A9W:UK 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.